We are live on ! Find out more
CIM

CIM Investment Management Portfolio holdings

AUM $375M
1-Year Est. Return 32.03%
This Fund
S&P 500
This Quarter Est. Return
+20.87%
1 Year Est. Return
+32.03%
3 Year Est. Return
+88.62%
5 Year Est. Return
+95.83%
10 Year Est. Return
+334.77%
AUM
$248M
AUM Growth
+$43.9M
Cap. Flow
+$3.83M
Cap. Flow %
1.54%
Top 10 Hldgs %
47.79%
Holding
273
New
76
Increased
56
Reduced
27
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 11.48%
2 Healthcare 10.05%
3 Financials 8.39%
4 Communication Services 6.69%
5 Consumer Staples 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZTS icon
126
Zoetis
ZTS
$30.9B
$408K 0.16%
+2,975
New +$388K
ESPR
127
DELISTED
Esperion Therapeutics
ESPR
$390K 0.16%
+7,604
New +$318K
CNC icon
128
Centene
CNC
$32.9B
$389K 0.16%
6,125
SCHW
129
Charles Schwab
SCHW
$188B
$387K 0.16%
11,474
UAL icon
130
United Airlines
UAL
$40.2B
$382K 0.15%
11,041
OGS icon
131
ONE Gas
OGS
$4.96B
$381K 0.15%
4,946
+2,055
+71% +$166K
BIIB icon
132
Biogen
BIIB
$30.6B
$380K 0.15%
1,419
MKTX icon
133
MarketAxess Holdings
MKTX
$5.72B
$378K 0.15%
754
-2,258
-75% -$1.05M
TWTR
134
DELISTED
Twitter, Inc.
TWTR
$378K 0.15%
12,701
-12,713
-50% -$383K
CORT icon
135
Corcept Therapeutics
CORT
$12.3B
$377K 0.15%
22,390
-5,412
-19% -$76K
AES icon
136
AES
AES
$10.5B
$375K 0.15%
+25,857
New +$340K
WDFC icon
137
WD-40
WDFC
$3.15B
$362K 0.15%
1,827
+428
+31% +$77.6K
ENSG icon
138
The Ensign Group
ENSG
$10.7B
$356K 0.14%
+8,516
New +$338K
ACIW icon
139
ACI Worldwide
ACIW
$5.34B
$353K 0.14%
13,081
+2,226
+21% +$58.2K
TFC icon
140
Truist Financial
TFC
$63.4B
$353K 0.14%
9,403
EOG icon
141
EOG Resources
EOG
$74.6B
$350K 0.14%
6,903
AIMT
142
DELISTED
Aimmune Therapeutics
AIMT
$350K 0.14%
20,938
+6,169
+42% +$105K
MO icon
143
Altria Group
MO
$109B
$349K 0.14%
8,897
CIR
144
DELISTED
CIRCOR International, Inc
CIR
$348K 0.14%
+13,650
New +$213K
QTWO icon
145
Q2 Holdings
QTWO
$3.96B
$346K 0.14%
+4,037
New +$310K
ELV icon
146
Elevance Health
ELV
$86.2B
$345K 0.14%
1,313
EQIX icon
147
Equinix
EQIX
$103B
$341K 0.14%
485
-478
-50% -$323K
LIVN icon
148
LivaNova
LIVN
$4.21B
$341K 0.14%
+7,085
New +$355K
MMS icon
149
Maximus
MMS
$2.9B
$341K 0.14%
+4,834
New +$325K
NTAP icon
150
NetApp
NTAP
$39B
$340K 0.14%
7,662

Similar funds

CIM Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, CIM Investment Management held 273 positions worth $248M, up 21% from $204M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

CIM Investment Management's Q2 2020 filing shows 76 new, 56 increased, 27 reduced and 21 closed positions. Its largest new stake was Bristol-Myers Squibb: 15,034 shares worth $884K. The largest sale was iShares Core S&P 500 ETF, an estimated $15.4M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Financials.

  • CIM Investment Management's largest Q2 2020 buy was Bristol-Myers Squibb: 15,034 shares worth $884K.
  • CIM Investment Management added most to iShares Core S&P Mid-Cap ETF in Q2 2020, an estimated $2.35M increase.
  • CIM Investment Management's biggest Q2 2020 reduction was iShares Core S&P 500 ETF, cutting an estimated $15.4M.
  • CIM Investment Management fully exited Raytheon Company in Q2 2020, selling an estimated $909K.
  • CIM Investment Management's ten largest holdings make up 48% of its $248M portfolio in Q2 2020.
  • CIM Investment Management opened 76 new positions and closed 21 in Q2 2020.
  • CIM Investment Management's portfolio value rose 21% quarter-over-quarter to $248M.

Based on CIM Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.